Company Encyclopedia
View More
name
Marubi
603983.SH
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names.
254.27 B
603983.SHMarket value -Rank by Market Cap -/-

Financial Score

23/12/2025 Update
B
Personal Care ProductsIndustry
Industry Ranking3/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE10.35%B
    • Profit Margin10.00%B
    • Gross Margin75.91%A
  • Growth ScoreB
    • Revenue YoY31.28%A
    • Net Profit YoY6.88%C
    • Total Assets YoY9.28%B
    • Net Assets YoY-1.52%D
  • Cash ScoreB
    • Cash Flow Margin1000.18%B
    • OCF YoY31.28%A
  • Operating ScoreB
    • Turnover0.75B
  • Debt ScoreB
    • Gearing Ratio30.03%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Guangdong Marubi Biotechnology submits Hong Kong listing application

    Guangdong Marubi Biotechnology submits Hong Kong listing application

    marketscreener·
    SH
    603983
    -0.91%
    marketscreener·
    SH
    603983
    -0.91%

    Guangdong Marubi Biotechnology To Seek Hong Kong Listing

    Guangdong Marubi Biotechnology Co Ltd :SAYS IT PLANS TO SEEK HONG KONG LISTING

    Reuters·
    SH
    603983
    -0.91%
    Reuters·
    SH
    603983
    -0.91%

    Marubi: The net profit for the third quarter was 69.4816 million yuan, a year-on-year increase of 11.59%

    Marubi announced that its revenue for the third quarter was 686 million yuan, a year-on-year increase of 14.28%; net profit was 69.4816 million yuan, a year-on-year increase of 11.59%. Revenue for the first three quarters was 2.45 billion yuan, a year-on-year increase of 25.51%; net profit was 244 million yuan, a year-on-year increase of 2.13%

    Zhitong·
    SH
    603983
    -0.91%
    Zhitong·
    SH
    603983
    -0.91%

    Marubi fell 6.76% today, with 4 institutional special seats net selling 117 million yuan

    Marubi fell 6.76% today, with a transaction amount of 411 million yuan and a turnover rate of 2.44%. According to the after-hours dragon and tiger list data, the Shanghai Stock Connect dedicated seat bought 14.5546 million yuan and sold 12.6801 million yuan. One institutional dedicated seat had a net purchase of 5.8066 million yuan, while four institutional dedicated seats had a net sale of 117 million yuan

    Zhitong·
    SH
    603983
    -0.91%
    Zhitong·
    SH
    603983
    -0.91%

    West China Securities: Maintains "Buy" rating on Marubi, brand focuses on the big product strategy and continues to strengthen efforts

    Huaxi Securities maintains a "Buy" rating on Marubi, expecting a net profit attributable to the parent company of 186 million yuan in H1 2025, a year-on-year increase of 5.21%. The net profit attributable to the parent company in Q2 2025 is expected to be 51 million yuan, a year-on-year decrease of 23.08%. The company plans to distribute a cash dividend of 2.5 yuan per share, with a dividend payout ratio of 53.97%. Marubi is developing synergistically with the PL Lianhuo brand, steadily increasing market penetration. The Shanghai Moyang Biotechnology Co., Ltd. invested in 2025 has obtained a Class III medical device registration certificate, demonstrating forward-looking layout. The brand focuses on a big product strategy, with classic products performing exceptionally well

    Zhitong·
    SH
    603983
    -0.91%
    Zhitong·
    SH
    603983
    -0.91%
    © 2025 Longbridge｜Disclaimer